A Comprehensive Review of Hepatitis B Vaccine Nonresponse and Associated Risk Factors

Autor: Albashir Tahir, Sa’adatu Haruna Shinkafi, Ahmed Subeh Alshrari, Abdulmajeed Yunusa, Muhammad Tukur Umar, Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh

Publikováno v: Vaccines, Vol 12, Iss 7, p 710 (2024)

Hepatitis B virus (HBV) infection remains a significant global health concern worldwide, contributing to high rates of mortality and morbidity, including chronic hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC). Universal vaccination progra

Externí odkaz: https://doaj.org/article/e12b16025ab64ca58d7d2d3c562b2afb

Hepatitis B Therapeutic Vaccine: A Patent Review

Autor: Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Kasimu Ghandi Ibrahim, Ahmed Subeh Alshrari

Publikováno v: Pharmaceuticals, Vol 15, Iss 12, p 1542 (2022)

Viral hepatitis has long been underrated as a danger to global health. The UN only recently called for worldwide action to tackle viral hepatitis and lessen the disease burden in its “2030 Agenda for Sustainable Development”. Hepatitis B virus (H

Externí odkaz: https://doaj.org/article/a3dc16b6045f427084943a25af2e78f1

Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades

Autor: Mohd. Imran, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Dhanalekshmi Unnikrishnan Meenakshi, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Yahya Mohzari, Ahmed Alrashed, Mohammed AlMotairi, Eman H. Alkhaldi, Abeer K. Alorabi, Ahmed Subeh Alshrari, Mohammad Tauseef, Abida, Saleh I. Alaqel, Ozair Alam, Md. Afroz Bakht

Publikováno v: Pharmaceuticals, Vol 14, Iss 8, p 710 (2021)

Protein kinase inhibitors (PKIs) are important therapeutic agents. As of 31 May 2021, the United States Food and Drug Administration (USFDA) has approved 70 PKIs. Most of the PKIs are employed to treat cancer and inflammatory diseases. Imatinib was t

Externí odkaz: https://doaj.org/article/042149ad6a3b48718874cc85daad4177

Cell Culture, Technology: Enhancing the Culture of Diagnosing Human Diseases

Autor: Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Ahmad Syahida, Zamberi Sekawi

Publikováno v: Journal of Clinical and Diagnostic Research, Vol 10, Iss 3, Pp DE01-DE05 (2016)

Cell culture involves a complex of processes of cell isolation from their natural environment (in vivo) and subsequent growth in a controlled environmental artificial condition (in vitro). Cells from specific tissues or organs are cultured as short

Externí odkaz: https://doaj.org/article/f46415f5eb934b0bab0a594a50634f93

Innovations and development of Covid-19 vaccines: A patent review

Autor: Shuaibu Abdullahi Hudu, Mohd. Imran, Ahmed Subeh Alshrari, Syed Imam Rabbani, Alreshidi Mateq Ali, Syed Mohammed Basheeruddin Asdaq

Publikováno v: ORCID
Microsoft Academic Graph
DOAJ-Articles
PubMed Central
Journal of Infection and Public Health
Journal of Infection and Public Health, Vol 15, Iss 1, Pp 123-131 (2022)

More than 125 million confirmed cases of COVID-19 have been reported globally with rising cases in all countries since the first case was reported. A vaccine is the best measure for the effective prevention and control of COVID-19. There are more tha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a15485bf9b49e655318cf1ba93680b2
https://doi.org/10.1016/j.jiph.2021.10.021